142 related articles for article (PubMed ID: 11907295)
1. Treatment of primary pulmonary hypertension -- the next generation.
Newman JH
N Engl J Med; 2002 Mar; 346(12):933-5. PubMed ID: 11907295
[No Abstract] [Full Text] [Related]
2. Recent advances in pulmonary vascular disease.
Adatia I
Curr Opin Pediatr; 2002 Jun; 14(3):292-7. PubMed ID: 12011667
[TBL] [Abstract][Full Text] [Related]
3. Developments in therapeutics for pulmonary arterial hypertension.
Wilkins MR; Møller GM; Ren X; Wharton J
Minerva Cardioangiol; 2002 Jun; 50(3):175-87. PubMed ID: 12107399
[TBL] [Abstract][Full Text] [Related]
4. Changing perceptions in pulmonary hypertension.
Gerges C; Lang IM
Lancet Respir Med; 2014 Jan; 2(1):21-3. PubMed ID: 24461891
[No Abstract] [Full Text] [Related]
5. [Endothelin receptor blockers--one more agent for the treatment of pulmonary hypertension].
Minushkina LO; Zateĭshchikov DA; Sidorenko BA
Kardiologiia; 2003; 43(9):67-71. PubMed ID: 14593372
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-receptor antagonists in pulmonary hypertension.
Dupuis J
Lancet; 2001 Oct; 358(9288):1113-4. PubMed ID: 11597660
[No Abstract] [Full Text] [Related]
7. [Updated treatment of primary pulmonary hypertension -- the role of endothelin receptor antagonists].
Callejas Rubio JL; Ortego Centeno N; Navarro Pelayo F; Vallejo Rodríguez I
Farm Hosp; 2004; 28(4):294-5. PubMed ID: 15369441
[No Abstract] [Full Text] [Related]
8. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
Humbert M
Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866
[No Abstract] [Full Text] [Related]
9. [Blockade of endothelin receptor with bosentan--a new principle of treatment in pulmonary arterial hypertension].
Nielsen-Kudsk JE
Ugeskr Laeger; 2003 Jul; 165(29):2891-4. PubMed ID: 12908360
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-receptor antagonism: the future is bright.
Dhaun N; Webb DJ
Lancet; 2008 Jun; 371(9630):2061-2. PubMed ID: 18572063
[No Abstract] [Full Text] [Related]
11. [Mutations of genes coding for TGF-beta receptors (BMPR2 and ALK-1) in primary pulmonary arterial hypertension].
Humbert M
J Soc Biol; 2002; 196(1):53-8. PubMed ID: 12134634
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary hypertension].
Olschewski H; Ghofrani A; Wiedemann R; Rose F; Enke B; Gessler T; Voswinckel R; Kohstall M; Grimminger F; Seeger W
Internist (Berl); 2002 Dec; 43(12):1498, 1501-9. PubMed ID: 12607389
[No Abstract] [Full Text] [Related]
13. [Endothelin-receptor antagonists in therapy of pulmonary arterial hypertension].
Ghofrani HA
Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S177-8. PubMed ID: 19718611
[No Abstract] [Full Text] [Related]
14. Has the 6-min walk distance run its course?
McLaughlin VV
Chest; 2012 Dec; 142(6):1363-1365. PubMed ID: 23208324
[No Abstract] [Full Text] [Related]
15. Selective or nonselective endothelin receptor blockade in pulmonary arterial hypertension.
Wilkins MR
Am J Respir Crit Care Med; 2004 Feb; 169(4):433-4. PubMed ID: 14766656
[No Abstract] [Full Text] [Related]
16. Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension.
Langleben D
Clin Chest Med; 2007 Mar; 28(1):117-25, viii. PubMed ID: 17338931
[TBL] [Abstract][Full Text] [Related]
17. Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration.
Burger CD
Ann Am Thorac Soc; 2015 Jun; 12(6):959. PubMed ID: 26075561
[No Abstract] [Full Text] [Related]
18. Reply: Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration.
Hill NS; Badesch D; Benza RL; D'Eletto TA; Farber HW; Gomberg-Maitland M; Hassoun PM; Preston I
Ann Am Thorac Soc; 2015 Jun; 12(6):960. PubMed ID: 26075562
[No Abstract] [Full Text] [Related]
19. Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene.
Tuder RM; Yeager ME; Geraci M; Golpon HA; Voelkel NF
Eur Respir J; 2001 Jun; 17(6):1065-9. PubMed ID: 11491145
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood.
Harrison RE; Berger R; Haworth SG; Tulloh R; Mache CJ; Morrell NW; Aldred MA; Trembath RC
Circulation; 2005 Feb; 111(4):435-41. PubMed ID: 15687131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
